<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pandemic</title>
	<atom:link href="https://www.worldpharmatoday.com/topics/pandemic/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Wed, 31 Dec 2025 08:13:38 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>Pandemic</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Building Resilient Pharma Portfolios in an Era of Scientific and Market Uncertainty</title>
		<link>https://www.worldpharmatoday.com/news/building-resilient-pharma-portfolios-in-an-era-of-scientific-and-market-uncertainty/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Wed, 24 Dec 2025 08:26:57 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Research Insight]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Biopharmaceutical Development]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[mRNA]]></category>
		<category><![CDATA[Pandemic]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/building-resilient-pharma-portfolios-in-an-era-of-scientific-and-market-uncertainty/</guid>

					<description><![CDATA[<p>Pharmaceutical companies are radically redesigning portfolio strategies to survive a "triple threat" environment of scientific complexity, regulatory upheaval like the IRA, and capital scarcity. This analysis explores the shift from efficiency-driven models to resilience-first frameworks, detailing how leaders are embedding optionality into pipelines, embracing modality agnosticism, and using dynamic resource allocation to thrive amidst volatility.</p>
The post <a href="https://www.worldpharmatoday.com/news/building-resilient-pharma-portfolios-in-an-era-of-scientific-and-market-uncertainty/">Building Resilient Pharma Portfolios in an Era of Scientific and Market Uncertainty</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Onshoring of Drug Product Manufacturing to Massachusetts</title>
		<link>https://www.worldpharmatoday.com/news/onshoring-of-drug-product-manufacturing-to-massachusetts/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 25 Nov 2025 13:30:19 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Production & Manufacturing]]></category>
		<category><![CDATA[Biopharma Businesses]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[mRNA]]></category>
		<category><![CDATA[Pandemic]]></category>
		<category><![CDATA[Vaccination]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/onshoring-of-drug-product-manufacturing-to-massachusetts/</guid>

					<description><![CDATA[<p>Moderna is set to expand its US manufacturing capabilities through the onshoring of drug product manufacturing to its present Moderna Technology Center &#8211; MTC located Norwood, Massachusetts, in a move that involves an investment of over $140m. By way of this onshoring, the company is now going to operate complete end-to-end mRNA medicine manufacturing throughout the country. It [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/news/onshoring-of-drug-product-manufacturing-to-massachusetts/">Onshoring of Drug Product Manufacturing to Massachusetts</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
